Alberti A - Search Results

1

Alberti A, Benvegnù L. Alberti A, et al. J Hepatol. 2003;38 Suppl 1:S104-18. doi: 10.1016/s0168-8278(03)00008-4. J Hepatol. 2003. PMID: 12591189 Review. No abstract available.

2

Therapy of acute hepatitis C.

Alberti A, Boccato S, Vario A, Benvegnù L. Alberti A, et al. Hepatology. 2002 Nov;36(5 Suppl 1):S195-200. doi: 10.1053/jhep.2002.36808. Hepatology. 2002. PMID: 12407594 Review.

3

Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection.

Alberti A, Noventa F, Benvegnù L, Boccato S, Gatta A. Alberti A, et al. Ann Intern Med. 2002 Dec 17;137(12):961-4. doi: 10.7326/0003-4819-137-12-200212170-00009. Ann Intern Med. 2002. PMID: 12484711

4

Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology.

Calabrese F, Valente M, Giacometti C, Pettenazzo E, Benvegnu L, Alberti A, Gatta A, Pontisso P. Calabrese F, et al. Among authors: alberti a. J Gastroenterol Hepatol. 2003 Nov;18(11):1302-8. doi: 10.1046/j.1440-1746.2003.03162.x. J Gastroenterol Hepatol. 2003. PMID: 14535988

5

Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels.

Alberti A. Alberti A. J Hepatol. 2005 Feb;42(2):266-74. doi: 10.1016/j.jhep.2004.12.004. J Hepatol. 2005. PMID: 15664254 Review. No abstract available.

6

Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study.

Romano A, Angeli P, Piovesan S, Noventa F, Anastassopoulos G, Chemello L, Cavalletto L, Gambato M, Russo FP, Burra P, Vincenzi V, Scotton PG, Panese S, Tempesta D, Bertin T, Carrara M, Carlotto A, Capra F, Carolo G, Scroccaro G, Alberti A. Romano A, et al. Among authors: alberti a. J Hepatol. 2018 Aug;69(2):345-352. doi: 10.1016/j.jhep.2018.03.009. Epub 2018 Mar 16. J Hepatol. 2018. PMID: 29551707

7

Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.

Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, Ferrari A, Alberti A. Sebastiani G, et al. Among authors: alberti a. J Hepatol. 2006 Apr;44(4):686-93. doi: 10.1016/j.jhep.2006.01.007. Epub 2006 Feb 8. J Hepatol. 2006. PMID: 16490278

8

Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience.

Alberti A, Angarano G, Colombo M, Craxì A, Di Marco V, Di Perri G, Gaeta GB, Ippolito G, Mangia A, Pasqualetti P. Alberti A, et al. Clin Res Hepatol Gastroenterol. 2019 Apr;43(2):190-200. doi: 10.1016/j.clinre.2018.09.007. Epub 2018 Oct 28. Clin Res Hepatol Gastroenterol. 2019. PMID: 30377096 Free article.

9

What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?

Alberti A. Alberti A. Liver Int. 2009 Jan;29 Suppl 1:15-8. doi: 10.1111/j.1478-3231.2008.01945.x. Liver Int. 2009. PMID: 19207961 Review.

10

The evolution of the therapeutic strategy in hepatitis C: features of sofosbuvir and indications.

Alberti A, Piovesan S. Alberti A, et al. Dig Liver Dis. 2014 Dec 15;46 Suppl 5:S174-8. doi: 10.1016/j.dld.2014.09.028. Epub 2014 Nov 11. Dig Liver Dis. 2014. PMID: 25458777 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,157 results

Search Page

Filters